Compare ZNTL & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZNTL | STRW |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.5M | 151.1M |
| IPO Year | 2020 | N/A |
| Metric | ZNTL | STRW |
|---|---|---|
| Price | $2.50 | $12.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $6.60 | ★ $12.33 |
| AVG Volume (30 Days) | ★ 1.1M | 24.3K |
| Earning Date | 03-25-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 5.12% |
| EPS Growth | N/A | ★ 19.41 |
| EPS | N/A | ★ 0.61 |
| Revenue | $26,865,000.00 | ★ $145,392,000.00 |
| Revenue This Year | N/A | $35.42 |
| Revenue Next Year | N/A | $7.19 |
| P/E Ratio | ★ N/A | $20.57 |
| Revenue Growth | N/A | ★ 29.76 |
| 52 Week Low | $1.01 | $8.70 |
| 52 Week High | $3.95 | $14.00 |
| Indicator | ZNTL | STRW |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 38.15 |
| Support Level | $2.21 | $12.80 |
| Resistance Level | $2.85 | $13.45 |
| Average True Range (ATR) | 0.29 | 0.41 |
| MACD | -0.09 | -0.08 |
| Stochastic Oscillator | 25.93 | 10.54 |
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.